Market Research Report
Novel Technologies Driving Infectious Disease Management
|Published by||Frost & Sullivan||Product code||883627|
|Published||Content info||45 Pages
Delivery time: 1-2 business days
|Novel Technologies Driving Infectious Disease Management|
|Published: June 26, 2019||Content info: 45 Pages||
Upcoming Technologies for Infectious Disease Diagnosis
This research service covers emerging diagnostic technologies that can transform infectious disease management.
Application of bioinformatics, artificial intelligence, and computational approaches: Next-generation sequencing (NGS) has revolutionized life sciences and healthcare. However, current laboratory-based approaches are still slow and time intensive. Advances in artificial intelligence (AI), computer programming, bioinformatics tools, and cloud technology have enabled generation of sophisticated databases. NGS along with these diverse approaches are transforming pathogen identification and provide more targeted and actionable treatments. Selected novel approached are described in this research service.
Nanopore Technology: New developments in nanotechnology are being applied to miniaturizing the devices for portable and field-based applications. Nanoscale lab-on-chip devices require minimum amount of biological sample. Nano devices are developed for NGS, detection of proteins and other biological analyte and have wide applications from clinical, agriculture to forensic and even space research. This research service summarizes two leading players and their nanopore technologies.